Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Inosine, chemically known as 9-β-D-ribofuranosylhypoxanthine, is a naturally occurring nucleoside formed by the attachment of hypoxanthine to a ribose sugar via a β-N9-glycosidic bond. Its molecular formula is C10H12N4O5, and it is widely recognized by its CAS registry number 58-63-9. As a fundamental building block in biological systems, Inosine plays a critical role in cellular metabolism and energy transfer processes. It serves as a precursor for both purine nucleotides and RNA synthesis, making it essential for DNA repair, cell proliferation, and protein synthesis.
Beyond its physiological significance, Inosine has garnered substantial attention in pharmaceutical and research applications. In clinical settings, it is utilized as a dietary supplement to support cardiovascular health and enhance athletic performance by improving oxygen delivery to tissues and reducing fatigue. Studies suggest that Inosine may help alleviate symptoms associated with ischemic heart disease and improve recovery times after physical exertion due to its ability to modulate adenosine receptors and boost ATP production. Furthermore, researchers are investigating its potential neuroprotective properties, particularly in treating conditions like amyotrophic lateral sclerosis (ALS) and spinal cord injuries, where it may promote neuronal regeneration and synaptic plasticity.
In the laboratory context, Inosine is frequently employed as a reagent in biochemical assays and enzymatic reactions. Its unique structure allows it to pair with cytosine during transcription, facilitating specific mutations or modifications in genetic studies. Additionally, it is used in the synthesis of various antiviral drugs and immunomodulators. The compound is generally available in high purity grades suitable for analytical chemistry, molecular biology, and drug development. While natural sources include yeast extracts and certain plant tissues, commercial production often relies on enzymatic conversion from inosinic acid. Overall, Inosine remains a versatile molecule bridging basic science and therapeutic innovation, offering promising avenues for future medical advancements while maintaining a strong safety profile when administered under proper guidelines.